{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:48:27Z","timestamp":1790527707700,"version":"4.1.0"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00897","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T04:30:03Z","timestamp":1524803403000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future"],"prefix":"10.3389","volume":"9","author":[{"given":"Gloria Hoi Wan","family":"Tso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Reales-Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/pathogens5010006","article-title":"How chemotherapy increases the risk of systemic candidiasis in cancer patients: current paradigm and future directions","volume":"5","author":"Teoh","year":"2016","journal-title":"Pathogens"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.2146\/ajhp080325","article-title":"Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients","volume":"66","author":"Menzin","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"B4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1469-0691.2008.01978.x","article-title":"Changing epidemiology of systemic fungal infections","volume":"14","author":"Richardson","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/jac\/dks019","article-title":"Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey","volume":"67","author":"Peman","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/cid\/cis697","article-title":"Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011","volume":"55","author":"Cleveland","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ijid.2016.09.018","article-title":"Epidemiology, microbiology, clinical characteristics, and outcomes of candidemia in internal medicine wards-a retrospective study","volume":"52","author":"Eliakim-Raz","year":"2016","journal-title":"Int J Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/01.inf.0000253973.89097.c0","article-title":"Excess costs of hospital care associated with neonatal candidemia","volume":"26","author":"Smith","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological trends in skin mycoses worldwide","volume":"51","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0002-9378(98)80001-X","article-title":"Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations","volume":"178","author":"Sobel","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1128\/CMR.00051-08","article-title":"Efflux-mediated antifungal drug resistance","volume":"22","author":"Cannon","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1126\/science.1128242","article-title":"Aneuploidy and isochromosome formation in drug-resistant Candida albicans","volume":"313","author":"Selmecki","year":"2006","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J Clin Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1093\/cid\/cit136","article-title":"Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations","volume":"56","author":"Alexander","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4155\/fmc-2016-0051","article-title":"The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies","volume":"8","author":"Reales-Calderon","year":"2016","journal-title":"Future Med Chem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.15167\/2421-4248\/jpmh2008.49.2.119","article-title":"Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey","volume":"49","author":"Fadda","year":"2008","journal-title":"J Prev Med Hyg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1128\/AAC.48.10.3773-3781.2004","article-title":"Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor","volume":"48","author":"Vermitsky","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"B23","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1365-2958.2006.05235.x","article-title":"Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies","volume":"61","author":"Vermitsky","year":"2006","journal-title":"Mol Microbiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/14787210.2017.1364992","article-title":"Candida auris: a worrisome, globally emerging pathogen","volume":"15","author":"Navalkele","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"B25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3201\/eid2302.152042","article-title":"Delivering on antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities","volume":"23","author":"Denning","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"B26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1128\/IAI.51.2.668-674.1986","article-title":"Evidence for macrophage-mediated protection against lethal Candida albicans infection","volume":"51","author":"Bistoni","year":"1986","journal-title":"Infect Immun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1002\/pmic.200400929","article-title":"Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine","volume":"4","author":"Fernandez-Arenas","year":"2004","journal-title":"Proteomics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/pmic.200701056","article-title":"Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice","volume":"8","author":"Martinez-Lopez","year":"2008","journal-title":"Proteomics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CVI.00480-08","article-title":"Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis","volume":"16","author":"Saville","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.mycres.2008.11.016","article-title":"Non-lethal Candida albicans cph1\/cph1 efg1\/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells","volume":"113","author":"Yang","year":"2009","journal-title":"Mycol Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1016\/j.vaccine.2009.03.030","article-title":"Saccharomyces cerevisiae as a vaccine against coccidioidomycosis","volume":"27","author":"Capilla","year":"2009","journal-title":"Vaccine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1099\/jmm.0.033290-0","article-title":"Saccharomyces as a vaccine against systemic aspergillosis: \u2018the friend of man\u2019 a friend again?","volume":"60","author":"Liu","year":"2011","journal-title":"J Med Microbiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3109\/08820139.2012.692418","article-title":"Saccharomyces as a vaccine against systemic candidiasis","volume":"41","author":"Liu","year":"2012","journal-title":"Immunol Invest"},{"key":"B34","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11046-014-9798-5","article-title":"Killed Saccharomyces cerevisiae protects against lethal challenge of Cryptococcus grubii","volume":"178","author":"Majumder","year":"2014","journal-title":"Mycopathologia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1128\/IAI.73.9.6191-6193.2005","article-title":"The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice","volume":"73","author":"Spellberg","year":"2005","journal-title":"Infect Immun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1128\/IAI.74.5.3039-3041.2006","article-title":"The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis","volume":"74","author":"Ibrahim","year":"2006","journal-title":"Infect Immun"},{"key":"B37","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1086\/504691","article-title":"Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis","volume":"194","author":"Spellberg","year":"2006","journal-title":"J Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17\u2009cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1128\/IAI.70.5.2725-2729.2002","article-title":"Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis","volume":"70","author":"De Bernardis","year":"2002","journal-title":"Infect Immun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"De Bernardis","year":"2012","journal-title":"Vaccine"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1016\/j.vaccine.2004.07.005","article-title":"Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL\/6 mice","volume":"23","author":"Yang","year":"2005","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e25909","DOI":"10.1371\/journal.pone.0025909","article-title":"Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis","volume":"6","author":"Luo","year":"2011","journal-title":"PLoS One"},{"key":"B44","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1002\/pmic.200600321","article-title":"A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis","volume":"6","author":"Thomas","year":"2006","journal-title":"Proteomics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/sji.12044","article-title":"Effect of branched alpha-oligomannoside structures on induction of anti-Candida humoral immune response","volume":"77","author":"Paulovicova","year":"2013","journal-title":"Scand J Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.vaccine.2009.12.021","article-title":"A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique","volume":"28","author":"Pietrella","year":"2010","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fimmu.2011.00021","article-title":"Edward Jenner and the small pox vaccine","volume":"2","author":"Smith","year":"2011","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","article-title":"Nonfilamentous C. albicans mutants are avirulent","volume":"90","author":"Lo","year":"1997","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fmicb.2016.00280","article-title":"Candida albicans agglutinin-like sequence (Als) family vignettes: a review of Als protein structure and function","volume":"7","author":"Hoyer","year":"2016","journal-title":"Front Microbiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1128\/IAI.00700-08","article-title":"The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus","volume":"76","author":"Spellberg","year":"2008","journal-title":"Infect Immun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.4049\/jimmunol.1200594","article-title":"A novel Th cell epitope of Candida albicans mediates protection from fungal infection","volume":"188","author":"Bar","year":"2012","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1099\/00221287-147-8-1997","article-title":"Candida albicans proteinases: resolving the mystery of a gene family","volume":"147","author":"Hube","year":"2001","journal-title":"Microbiology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","article-title":"Candida albicans secreted aspartyl proteinases in virulence and pathogenesis","volume":"67","author":"Naglik","year":"2003","journal-title":"Microbiol Mol Biol Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0378-1097(89)90071-2","article-title":"Cloning of a DNA sequence encoding a major fragment of the 47 kilodalton stress protein homologue of Candida albicans","volume":"51","author":"Matthews","year":"1989","journal-title":"FEMS Microbiol Lett"},{"key":"B57","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/JCM.25.2.230-237.1987","article-title":"Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans","volume":"25","author":"Matthews","year":"1987","journal-title":"J Clin Microbiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin Infect Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1128\/AAC.00435-12","article-title":"Nonspecific effect of Mycograb on amphotericin B MIC","volume":"56","author":"Richie","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"B61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrmicro1815","article-title":"An integrated model of the recognition of Candida albicans by the innate immune system","volume":"6","author":"Netea","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1172\/JCI27114","article-title":"Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and toll-like receptors","volume":"116","author":"Netea","year":"2006","journal-title":"J Clin Invest"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/mmi.12426","article-title":"Mannosylation in Candida albicans: role in cell wall function and immune recognition","volume":"90","author":"Hall","year":"2013","journal-title":"Mol Microbiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.4.1.1","article-title":"Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action","volume":"4","author":"Nelson","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/eji.1830270942","article-title":"Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells","volume":"27","author":"Tan","year":"1997","journal-title":"Eur J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jmii.2013.08.020","article-title":"Immune cell response to Candida cell wall mannan derived branched alpha-oligomannoside conjugates in mice","volume":"48","author":"Paulovicova","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"B67","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.41.11.2471","article-title":"Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-d-glucan synthase inhibitors","volume":"41","author":"Douglas","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"B68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ni1408","article-title":"Dectin-1 is required for beta-glucan recognition and control of fungal infection","volume":"8","author":"Taylor","year":"2007","journal-title":"Nat Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","article-title":"Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes","volume":"12","author":"Quintin","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1016\/j.vaccine.2010.01.012","article-title":"Beta-glucan-CRM197 conjugates as candidates antifungal vaccines","volume":"28","author":"Bromuro","year":"2010","journal-title":"Vaccine"},{"key":"B74","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fcimb.2016.00186","article-title":"Beta-glucan exposure on the fungal cell wall tightly correlates with competitive fitness of Candida species in the mouse gastrointestinal tract","volume":"6","author":"Sem","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/yea.1595","article-title":"A history of research on yeasts 12: medical yeasts part 1, Candida albicans","volume":"25","author":"Barnett","year":"2008","journal-title":"Yeast"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nm.4176","article-title":"Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation","volume":"22","author":"Fujimura","year":"2016","journal-title":"Nat Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1128\/JCM.44.5.1810-1820.2006","article-title":"Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract","volume":"44","author":"Bougnoux","year":"2006","journal-title":"J Clin Microbiol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nrmicro3156","article-title":"Development of vaccines for Candida albicans: fighting a skilled transformer","volume":"11","author":"Cassone","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fimmu.2012.00156","article-title":"Immunity and tolerance to fungi in hematopoietic transplantation: principles and perspectives","volume":"3","author":"Carvalho","year":"2012","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/j.1462-5822.2005.00616.x","article-title":"Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence","volume":"7","author":"Kumamoto","year":"2005","journal-title":"Cell Microbiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jhin.2009.02.009","article-title":"Candida colonisation as a source for candidaemia","volume":"72","author":"Miranda","year":"2009","journal-title":"J Hosp Infect"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1371\/journal.ppat.0040035","article-title":"Mucosal damage and neutropenia are required for Candida albicans dissemination","volume":"4","author":"Koh","year":"2008","journal-title":"PLoS Pathog"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1099\/mic.0.049395-0","article-title":"Hyphal induction in the human fungal pathogen Candida albicans reveals a characteristic wall protein profile","volume":"157","author":"Heilmann","year":"2011","journal-title":"Microbiology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1128\/EC.2.5.1053-1060.2003","article-title":"Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection","volume":"2","author":"Saville","year":"2003","journal-title":"Eukaryot Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1749-7922-8-38","article-title":"Surgical pathology and the diagnosis of invasive visceral yeast infection: two case reports and literature review","volume":"8","author":"Di Carlo","year":"2013","journal-title":"World J Emerg Surg"},{"key":"B86","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/ng.605","article-title":"Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity","volume":"42","author":"Noble","year":"2010","journal-title":"Nat Genet"},{"key":"B87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000321157","article-title":"Organ-specific innate immune responses in a mouse model of invasive candidiasis","volume":"3","author":"Lionakis","year":"2011","journal-title":"J Innate Immun"},{"key":"B88","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.mib.2009.09.010","article-title":"White-opaque switching in Candida albicans","volume":"12","author":"Lohse","year":"2009","journal-title":"Curr Opin Microbiol"},{"key":"B89","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1128\/IAI.65.11.4468-4475.1997","article-title":"Misexpression of the white-phase-specific gene WH11 in the opaque phase of Candida albicans affects switching and virulence","volume":"65","author":"Kvaal","year":"1997","journal-title":"Infect Immun"},{"key":"B90","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1128\/IAI.67.12.6652-6662.1999","article-title":"Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection","volume":"67","author":"Kvaal","year":"1999","journal-title":"Infect Immun"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e1003210","DOI":"10.1371\/journal.ppat.1003210","article-title":"Candida albicans white and opaque cells undergo distinct programs of filamentous growth","volume":"9","author":"Si","year":"2013","journal-title":"PLoS Pathog"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1473","DOI":"10.1371\/journal.pone.0001473","article-title":"Differential phagocytosis of white versus opaque Candida albicans by Drosophila and mouse phagocytes","volume":"3","author":"Lohse","year":"2008","journal-title":"PLoS One"},{"key":"B93","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/EC.00266-12","article-title":"White-opaque switching of Candida albicans allows immune evasion in an environment-dependent fashion","volume":"12","author":"Sasse","year":"2013","journal-title":"Eukaryot Cell"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.2710","article-title":"Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism","volume":"45","author":"Pande","year":"2013","journal-title":"Nat Genet"},{"key":"B95","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/EC.00060-10","article-title":"Genomic plasticity of the human fungal pathogen Candida albicans","volume":"9","author":"Selmecki","year":"2010","journal-title":"Eukaryot Cell"},{"key":"B96","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1365-2958.2008.06176.x","article-title":"An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1","volume":"68","author":"Selmecki","year":"2008","journal-title":"Mol Microbiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1101\/gr.174623.114","article-title":"Genetic and phenotypic intra-species variation in Candida albicans","volume":"25","author":"Hirakawa","year":"2015","journal-title":"Genome Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/myc.12623","article-title":"Phenotypic and genotypic characteristics of Candida albicans isolates from bloodstream and mucosal infections","volume":"60","author":"Mandelblat","year":"2017","journal-title":"Mycoses"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408410903241444","article-title":"Epidemiology of invasive mycoses in North America","volume":"36","author":"Pfaller","year":"2010","journal-title":"Crit Rev Microbiol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10096-006-0159-2","article-title":"Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies","volume":"25","author":"Falagas","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B101","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(03)00801-6","article-title":"Epidemiology of Candida species infections in critically ill non-immunosuppressed patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.1128\/JCM.01998-13","article-title":"Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain","volume":"51","author":"Bassetti","year":"2013","journal-title":"J Clin Microbiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.diagmicrobio.2010.06.015","article-title":"Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009)","volume":"68","author":"Pfaller","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B104","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/1469-0691.12539","article-title":"Global trends in the distribution of Candida species causing candidemia","volume":"20","author":"Guinea","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"B105","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/CMR.00013-08","article-title":"Candida parapsilosis, an emerging fungal pathogen","volume":"21","author":"Trofa","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"B106","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.diagmicrobio.2006.11.009","article-title":"Candidemia due to Candida tropicalis: clinical, epidemiologic, and microbiologic characteristics of 188 episodes occurring in tertiary care hospitals","volume":"58","author":"Nucci","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e01588-17","DOI":"10.1128\/JCM.01588-17","article-title":"Candida auris: an emerging fungal pathogen","volume":"56","author":"Spivak","year":"2018","journal-title":"J Clin Microbiol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.diagmicrobio.2009.03.010","article-title":"Epidemiology and outcome of multiple-species candidemia at a tertiary care center between 2004 and 2007","volume":"64","author":"Nace","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"B109","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.coi.2012.04.009","article-title":"T cell tolerance and immunity to commensal bacteria","volume":"24","author":"Nutsch","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.1073\/pnas.0909122107","article-title":"Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota","volume":"107","author":"Round","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B111","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"B114","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1002\/eji.201344406","article-title":"Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi","volume":"44","author":"Romani","year":"2014","journal-title":"Eur J Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/mi.2009.17","article-title":"Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans","volume":"2","author":"Bonifazi","year":"2009","journal-title":"Mucosal Immunol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4161\/21505594.2014.988096","article-title":"Host response to Candida albicans bloodstream infection and sepsis","volume":"6","author":"Duggan","year":"2015","journal-title":"Virulence"},{"key":"B117","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fcimb.2017.00481","article-title":"Modulating host signaling pathways to promote resistance to infection by Candida albicans","volume":"7","author":"Carpino","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"e1002865","DOI":"10.1371\/journal.ppat.1002865","article-title":"Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis","volume":"8","author":"Lionakis","year":"2012","journal-title":"PLoS Pathog"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e02365-16","DOI":"10.1128\/AAC.02365-16","article-title":"Pharmacological blockade of the chemokine receptor CCR1 protects mice from systemic candidiasis of hematogenous origin","volume":"61","author":"Lionakis","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1002\/cncr.30764","article-title":"Immunogenicity and safety of single-dose, 13-valent pneumococcal conjugate vaccine in pediatric and adolescent oncology patients","volume":"123","author":"Hung","year":"2017","journal-title":"Cancer"},{"key":"B122","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/tid.12359","article-title":"Low immunogenicity of quadrivalent meningococcal vaccines in solid organ transplant recipients","volume":"17","author":"Wyplosz","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"B123","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2217\/imt.13.171","article-title":"Influenza vaccination in immunocompromised patients: efficacy and safety","volume":"6","author":"Zbinden","year":"2014","journal-title":"Immunotherapy"},{"key":"B124","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1016\/j.vaccine.2016.04.053","article-title":"Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection","volume":"34","author":"Hakim","year":"2016","journal-title":"Vaccine"},{"key":"B125","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00430-016-0451-4","article-title":"Eradication of measles: remaining challenges","volume":"205","author":"Holzmann","year":"2016","journal-title":"Med Microbiol Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.vaccine.2013.09.034","article-title":"Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model","volume":"33","author":"Vickers","year":"2015","journal-title":"Vaccine"},{"key":"B127","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5863\/1551-6776-21.1.27","article-title":"A review of pneumococcal vaccines: current polysaccharide vaccine recommendations and future protein antigens","volume":"21","author":"Daniels","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"B128","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature17625","article-title":"Candidalysin is a fungal peptide toxin critical for mucosal infection","volume":"532","author":"Moyes","year":"2016","journal-title":"Nature"},{"key":"B129","doi-asserted-by":"publisher","first-page":"C14","DOI":"10.1016\/j.vaccine.2010.07.020","article-title":"Principles of vaccine design-lessons from nature","volume":"28","author":"Zepp","year":"2010","journal-title":"Vaccine"},{"key":"B130","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J Infect Dis"},{"key":"B131","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","article-title":"Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact","volume":"31","author":"Biering-Sorensen","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"B132","doi-asserted-by":"publisher","first-page":"c6495","DOI":"10.1136\/bmj.c6495","article-title":"Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial","volume":"341","author":"Aaby","year":"2010","journal-title":"BMJ"},{"key":"B133","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.it.2013.04.004","article-title":"A small jab\u2013\u2013a big effect: nonspecific immunomodulation by vaccines","volume":"34","author":"Benn","year":"2013","journal-title":"Trends Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B135","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/icb.2017.13","article-title":"Evaluation of trained immunity by beta-1, 3 (d)-glucan on murine monocytes in vitro and duration of response in vivo","volume":"95","author":"Garcia-Valtanen","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e108794","DOI":"10.1371\/journal.pone.0108794","article-title":"The effects of orally administered beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study","volume":"9","author":"Leentjens","year":"2014","journal-title":"PLoS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T09:34:33Z","timestamp":1604223273000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":137,"alternative-id":["10.3389\/fimmu.2018.00897"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00897","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"article-number":"897"}}